CONFORTI, FRANCESCO
CONFORTI, FRANCESCO
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
2021-01-01 Conforti F.; Pala L.; Pagan E.; Rocco E.G.; Bagnardi V.; Montagna E.; Peruzzotti G.; De Pas T.; Fumagalli C.; Pileggi S.; Pesenti C.; Marchini S.; Corso G.; Marchio' C.; Sapino A.; Graffeo R.; Collet L.; Aftimos P.; Sotiriou C.; Piccart M.; Gelber R.D.; Viale G.; Colleoni M.; Goldhirsch A.
Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)
2021-01-01 F. Conforti, M. Marino , V. Vitolo , L. Spaggiari , R. Mantegazza , P. Zucali , E. Ruffini , L. di Tommaso, G. Pelosi, M. Barberis, I. Petrini, G. Palmieri, G. Pasello, G. Galli, R. Berardi, M. Garassino, P. Filosso, M. Alloisio, M. Scorsetti, R. Orecchia, L. Pala , L. Abatedaga, S. Cinieri T. De Pas
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19
2020-01-01 Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations | 2021 | Conforti F.; Pala L.; Pagan E.; Rocco E.G.; Bagnardi V.; Montagna E.; Peruzzotti G.; De Pas T.; Fumagalli C.; Pileggi S.; Pesenti C.; Marchini S.; Corso G.; Marchio' C.; Sapino A.; Graffeo R.; Collet L.; Aftimos P.; Sotiriou C.; Piccart M.; Gelber R.D.; Viale G.; Colleoni M.; Goldhirsch A. | |
| Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM) | 2021 | F. Conforti, M. Marino , V. Vitolo , L. Spaggiari , R. Mantegazza , P. Zucali , E. Ruffini , L. di Tommaso, G. Pelosi, M. Barberis, I. Petrini, G. Palmieri, G. Pasello, G. Galli, R. Berardi, M. Garassino, P. Filosso, M. Alloisio, M. Scorsetti, R. Orecchia, L. Pala , L. Abatedaga, S. Cinieri T. De Pas | |
| Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 | 2020 | Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P. |